BRUSSELS: Europe’s medicines watchdog para koikena janaishe ki tai khan toh rare bloods clots laga reports khan toh sai thakishe charta manu khan uporte kun para covid19 vaccine paishe Janssen para bona toh.etu Johnson & Johnson laga pharmaceu tical laga arm ase.statement te European Medicines Agency (EMA) para koikena janaishe tai khan laga safety committee toh sabole kurishe etu reports pabole nimete thromboembolic events te etu toh blood clots khan olaishe aro etu para vessel toh manu khan nimete biya kurishe kun para Janssen Jab toh paishe. Xinhua news agency para Friday te report te koikena janaidiya thakishe.
Etu charta serious cases “unusual blood clots with low blood platelets,” te tinta toh United states te olaishe etu khan etu vaccine rollout shuru kurishe aro fourth toh olaishe clinical trial te.ekta manu murishe etu nimete.
EMA para koikena janaishe tai khan clear nai judi etu te link ase na nai vaccine aro reported conditions khan majhotte aro etu toh safety committee ase etu toh manibo judi regulatory action etu te label bodli kura lagi thaka ase.
Etu single-dose Janssen vaccine toh etia khali US te dikena ase emergency use authorisation bithor te ase.etu jab toh European Union (EU) March, te authorise kurishe hoilebi etu rollout toh etia tak shuru kuranai EU member state te ekta bi nai.
Aro koikena janaishe etu khan toh chanbin toh AstraZeneca’s jab laga chan bin te ase etu bi bleeding condition te ase.
EMA para koikena janaishe Friday din tai khan etu AstraZeneca Covid-19 vaccine and five reported cases capillary leak syndrome manu khan uporte kotha kurishe kun khan vaccine paishe.etu condition kuntu te blood leaks khan chotu waala blood vessels te muscles aro body cavities te etu toh swelling aro blood pressure te ase.
Olop haafta akhe te EMA para koikena janaishe AstraZeneca’s vaccine aro blood clots majhotte thaka ase.
Add Comment